IFNG and neoplasm: Additional IFN‐γ release from CD4+ T cells may also up‐regulate HLA‐I and HLA‐II molecules on the tumour cell surface, which may result in the recruitment of more tumour‐specific CD8+ and CD4+ T cells to the disease site 45, 46.